We are live on ! Find out more
VANI icon

Vivani Medical

33 hedge funds and large institutions have $4.45M invested in Vivani Medical in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $3.93M → $4.45M (+$522K)

0% more funds holding

Funds holding: 3333 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

1.21% less ownership

Funds ownership: 8.45%7.24% (-1.2%)

33% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 9

Holders
33
Holders Change
Holders Change %
0%
% of All Funds
0.52%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
6
Reduced
9
Closed
5
Calls
$14K
Puts
Net Calls
+$14K
Net Calls Change
+$13K

VANI Hedge Fund Activity: Q2 2023 in Review

33 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q2 2023, worth a combined $4.45M — up 13% from $3.93M a quarter earlier.

Fund positioning in VANI was balanced in Q2 2023: 5 funds opened new positions, 5 closed out, 6 added to existing stakes and 9 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $56K. The largest seller was Tanager Wealth Management, cutting an estimated $594K.

  • 33 institutional investors held Vivani Medical (VANI) as of Q2 2023, unchanged from Q1 2023.
  • Funds reported $4.45M of Vivani Medical stock for Q2 2023, up 13% quarter-over-quarter.
  • 5 funds opened new Vivani Medical positions in Q2 2023 and 5 closed out, a net change of 0 holders.
  • The largest Vivani Medical buyer in Q2 2023 was Geode Capital Management, an estimated $56K added.
  • The largest Vivani Medical seller in Q2 2023 was Tanager Wealth Management, an estimated $594K sold.

Based on aggregated 13F filings for Q2 2023.